Healthcare professionals today are faced with more patients to treat, more complex arrhythmias, widespread resource constraints and the need to bring cost-effective innovations to reduce cost burden. Medtronic’s versatile and efficient solutions in cardiac ablation are tailored to help respond to these challenges.
With single shot, wide area focal and focal capabilities, Medtronic’s solutions are designed to meet the needs of different patients with complex arrhythmias.
The complete portfolio includes the below range of catheters that deliver cryoablation, radiofrequency ablation and pulsed field ablation energies.
Arctic Front™ Cardiac Cryoablation catheter family – Simple, safe and effective PVI solution1 (including recently CE Marked Nitron CryoConsole™ Cardiac Cryoablation System and FlexCath Contour™ Steerable Sheath)
PulseSelect™ anatomical pulsed field ablation system
Wide area focal catheter
Affera™ Mapping and Ablation System – All-in-one solution to map, ablate and validate
Focal catheters
Diamond Temp™ - Real-time, temperature-controlled ablation
Freezor™ family of cardiac cryoablation catheters – the only cryo energy focal catheters
Innovations to enable further workflow efficiencies
More efficiency to address healthcare resource constraints
Medtronic’s cardiac ablation solutions streamline procedures and reduce their complexity. Straightforward, simple and safe tools help gain time back, create more capacity and save resources.
Streamline Arctic Front™ Advance™ Cryoballoon procedures:
- Increase procedure capacity with learnings from the Arctic Front™ Optimization Course
- Unlock underutilized EP lab space with a mobile and portable EP recording system, the EP-TRACER™
- Streamline your workflow with a zero exchange transseptal workflow: Flexcath Cross™
- Consider a same-day discharge model for your Cryoballoon ablation procedures
More evidence for better patient outcomes
- 1,800+ peer reviewed articles
- 10+ years of PFA research
- 20,000+patients enrolled in completed EU trials
Medtronic’s focus on generating robust pre-clinical and clinical evidence ensures the best outcomes for patients living with complex arrhythmias.
Medtronic supported evidence
Footnotes
*
FlexCath Cross™ is a trademark and manufactured by Acutus Medical and is exclusively distributed by Medtronic. ™*Third-party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.
Certain FlexCath Cross™ configurations are not CE marked nor commercially available in Europe. Please contact your Medtronic representative for more information. All rights reserved.
References
1
Chun KRJ, et al. Safety and efficacy of cryoballoon ablation for the treatment of paroxysmal and persistent AF in a real-world global setting: Results from the Cryo AF Global Registry; J Arrhythm. 2021 Jan 25;37(2):356-367.
© 2023 Medtronic. All rights reserved.